These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 11563018)

  • 1. Design and properties of hepatitis C virus antisense oligonucleotides for liver specific drug targeting.
    Lehmann TJ; Serwe M; Caselmann WH; Engels JW
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1343-6. PubMed ID: 11563018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and properties of bile acid phosphoramidites 5'-tethered to antisense oligodeoxynucleotides against HCV.
    Lehmann TJ; Engels JW
    Bioorg Med Chem; 2001 Jul; 9(7):1827-35. PubMed ID: 11425584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of hepatitis C viral gene expression by non-polar (phenylalkyl)phosphonates.
    Amberg S; Tamke A; Caselmann WH; Engels JW
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1631-4. PubMed ID: 14565483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of conjugates of oligodeoxynucleotides and lipid structures and their interaction with low-density lipoprotein.
    Rump ET; de Vrueh RL; Sliedregt LA; Biessen EA; van Berkel TJ; Bijsterbosch MK
    Bioconjug Chem; 1998; 9(3):341-9. PubMed ID: 9576808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers.
    Zimmer A
    Methods; 1999 Jul; 18(3):286-95, 322. PubMed ID: 10454987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotide-based therapeutic options against hepatitis C virus infection.
    Trepanier JB; Tanner JE; Alfieri C
    Antivir Ther; 2006; 11(3):273-87. PubMed ID: 16759043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of translation initiation region of c-myc mRNA and thermostability of the c-myc mRNA/antisense ODN complex.
    Tanaka T; Kurihara Y; Sakamoto T; Furusawa M; Kobayashi A; Katahira M; Takeuchi K; Sugimoto N; Uesugi S
    Nucleic Acids Symp Ser; 1995; (34):135-6. PubMed ID: 8841589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effects of chemically different linkers on hepatic accumulations, cell tropism and gene silencing ability of cholesterol-conjugated antisense oligonucleotides.
    Wada S; Yasuhara H; Wada F; Sawamura M; Waki R; Yamamoto T; Harada-Shiba M; Obika S
    J Control Release; 2016 Mar; 226():57-65. PubMed ID: 26855051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybridisation of [76Br]-labelled antisense oligonucleotides to Chromogranin A mRNA verified by RT-PCR.
    Wu F; Lendvai G; Yngve U; Eriksson B; Långström B; Bergström M
    Nucl Med Biol; 2004 Nov; 31(8):1073-8. PubMed ID: 15607489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells.
    Mizutani T; Kato N; Hirota M; Sugiyama K; Murakami A; Shimotohno K
    Biochem Biophys Res Commun; 1995 Jul; 212(3):906-11. PubMed ID: 7626129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
    Khan A; Sommer W; Fuxe K; Akhtar S
    J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic properties of several novel oligonucleotide analogs in mice.
    Crooke ST; Graham MJ; Zuckerman JE; Brooks D; Conklin BS; Cummins LL; Greig MJ; Guinosso CJ; Kornbrust D; Manoharan M; Sasmor HM; Schleich T; Tivel KL; Griffey RH
    J Pharmacol Exp Ther; 1996 May; 277(2):923-37. PubMed ID: 8627575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted polynucleotides for inhibition of hepatitis B and C viruses.
    Wu GY; Walton CM; Wu CH
    Croat Med J; 2001 Aug; 42(4):463-6. PubMed ID: 11471200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
    Lewis KJ; Irwin WJ; Akhtar S
    J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro toxicology and pharmacokinetics of antisense oligonucleotides.
    Crooke RM
    Anticancer Drug Des; 1991 Dec; 6(6):609-46. PubMed ID: 1772572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide.
    Fluiter K; Frieden M; Vreijling J; Rosenbohm C; De Wissel MB; Christensen SM; Koch T; Ørum H; Baas F
    Chembiochem; 2005 Jun; 6(6):1104-9. PubMed ID: 15861430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol-GalNAc Dual Conjugation Strategy for Reducing Renal Distribution of Antisense Oligonucleotides.
    Wada F; Yamamoto T; Ueda T; Sawamura M; Wada S; Harada-Shiba M; Obika S
    Nucleic Acid Ther; 2018 Feb; 28(1):50-57. PubMed ID: 29360004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformation of formacetal and 3'-thioformacetal nucleotide linkers and stability of their antisense RNA.DNA hybrid duplexes.
    Rice JS; Gao X
    Biochemistry; 1997 Jan; 36(2):399-411. PubMed ID: 9003193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of antisense oligonucleotides conjugated to a multivalent carbohydrate cluster for cellular targeting.
    Maier MA; Yannopoulos CG; Mohamed N; Roland A; Fritz H; Mohan V; Just G; Manoharan M
    Bioconjug Chem; 2003; 14(1):18-29. PubMed ID: 12526688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.